StoneX Group’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-769
Closed -$2.08K 690
2022
Q4
$2.08K Buy
+769
New +$2.08K ﹤0.01% 534